“borderline significant”

However, compared to immediately after cooling, the FTRS total was borderline significant 25′ after cooling ( p = 0.05) and significantly greater post-50′ cooling ( p < 0.0001).

There is a borderline significant effect (p=0.05) of adding cold air to induce a decrease in FEV 1 in patients with asthma.

eGFR significantly decreased during the follow-up period in both groups; The difference in the change in eGFR over time between the groups was borderline significant (interaction group × time, p = 0.05) (Table 2 ).

For rs743572 ( CYP17A1 ), the dominant model yielded a borderline significant association (OR = 1.56; 95% CI: 1.00–2.45; P = 0.05), reinforcing the increased risk observed for the C allele in the main analysis.

The long-term NATHAN 1 trial reported a marginal, borderline significant effect on the primary composite endpoint (NIS-LL, p = 0.05) without significant improvements in nerve conduction studies; therefore, evidence for functional stabilization is very limited and inconclusive.

Overall time had a borderline significant difference ( p = 0.05) for patients with a Q12-16 response (Table 3 , Fig. 5 ).

When looking at fatal CVDs we reported a borderline significant association with WPA (r pb = -0.045, p = 0.050).

Evaluation of systemic markers of inflammation (hs-CRP, IL-6, IL-8 and fibrinogen) only revealed a borderline significant decrease in plasma hs-CRP concentration after doxycycline treatment (−0.51 μg/ml, P =0.050; Table 3 ).

When adjusted for age and the number of comorbidities, the continuous cHIS score showed a borderline significant association with ICU mortality (OR 1.41, 95% CI 1.00–2.09, P = 0.050).

Analysis of variance (ANOVA) revealed a significant contribution of interval type in the main effects model ( F (1, 233) = 31.34, p < 0.001); the interaction of language type and interval type significantly improved the model fit in a second-order interaction model comparison, F (1, 229) = 10.01, p = 0.002; and the third-order interaction model also showed a borderline significant improvement ( F (3, 226) = 2.70, p = 0.05).

Regression analysis The univariable linear regression tests between AUC of post-meal SBP and age, BMI, sex, supine SBP, sinus arrhythmia ratio, the index ∆HR/∆BP and HR during phase IV of VM did not show any significant association, Table 3 ; however, the diagnosis (MSA or PD) had a borderline significant association with AUC of post-meal SBP ( P = 0.05).

For joint effects of metals, we found that co-exposure of Pb and Cd had a borderline significant association (p = 0.05) with low BMD, in current smokers, after adjustment for age, sex, region, income, and physical activity.

This was strongest for all ripples (r s = 0.43, p = 0.02) and Non-SpindleR (r s = 0.40, p = 0.03), but borderline significant for SpikeR (r s = 0.35, p = 0.05).

For progression to NV, a similar effect of BMI for type 1 carriers versus noncarriers was not seen: the effect of BMI among carriers was not significant (OR = 0.6; 95% CI = 0.2, 1.9; P = 0.33), whereas it was borderline significant among noncarriers (OR = 1.2; 95% CI = 1.0, 1.4; P = 0.05).

Indeed, mortality was not significantly different between rivaroxaban and warfarin in ROCKET-AF (the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation), whereas the mortality reduction was significant for apixaban (11% reduction) and borderline significant for dabigatran 150 mg twice daily (10% reduction, P=0.05), compared with warfarin in their respective phase 3 trials. 2 26 27 We found comparable bleeding rates for warfarin and rivaroxaban that were noticeably higher than for both apixaban and dabigatran.

Baseline correlation of CMR parameters and EAT EAT was positively correlated with LV mass ( r = 0.25, p = 0.01) and showed a borderline significant association with LVEF ( r = 0.2, p = 0.05).

Post hoc t -tests showed no difference between MDD and HC before treatment ( t (62) = −0.46, p = 0.644, Cohen’s d = 0.11), but a borderline significant difference after treatment ( t (62) = 1.99, p = 0.050, Cohen’s d = 0.51).

When grouped by the number of medications patients were on at the 20-year mark, there was a borderline significant difference between the groups on 0-1 (n=61), 2-4 (n=46) and ≥5 (n=39) different medications (10-year OS 93%, 93% and 76% respectively, p=0.05).

23); however, we noted a borderline significant increase in stress following the 4-week period after a COVID-19 diagnosis ( P = . 05).

Readmission rates showed a borderline significant difference across continence groups ( p = 0.05), whereas complication severity according to Clavien–Dindo classification did not differ significantly.

In a Cox-proportional hazard model where the cause-specific hazards were investigated ( Figure 1B ), eGFR was only borderline significant ( P = .05) for CV events.

The pooled MD was −24.89 s (95% CI: −50.29, 0.51), borderline significant favoring fluorescent adhesives ( p = 0.05), with very high heterogeneity ( I 2 = 99.77%, τ 2 = 967.50) (Figure 10 ). 3.10.

2 , 3 ); differences were only significant for fibrous volume and borderline significant for necrotic-core volume ( P < 0.05 and P = 0.07, respectively).

Overall bleeding complications were more frequently observed when antithrombotic drugs were used (borderline significant=0.051), in particular, in patients who used double antiplatelet therapy ( P <0.05).

And at best, reasonably expected data from that number (using 62% vs 50% success rates) might show a marginal advantage of successfully using an AVG over an AVF at a borderline significant P < 0.05 (but not P < 0.01).